Targeting of TAMs: can we be more clever than cancer cells?

Cell Mol Immunol · 2024 · PMC11607358 · PMID 39516356

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

In human prostate tumor samples taken before ADT, the density of perivascular FR-β+ CD68+ TAMs was significantly greater in patients who did not respond to ADT than in responders; there was also a nonsignificant trend for PV FR-β+ CD68+ TAMs to also be greater after ADT in nonresponders than in responders [ 174 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.